Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @MayoPharmRes
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MayoPharmRes
-
.
@HlavacekPharmD (PGY2 EM) will be presenting "Escaping Vaping: Where We Are and Where Go From Here" at Pharmacy Grand Rounds tomorrow, 2/4, at 11am in Alfred Main 459. Be sure not to miss this one!#TwitteRx#MedTwitter@MayoClinicEMpic.twitter.com/jZU9Zp4y1g
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With interviews in full swing, Rochester PGY1 RPD
@nei_scott has some#TipsForRxStudents - "if you made it to the interview, the program feels you are qualified. Fit is what's most important on interview day - don't get caught your perceived "mistakes" - focus on being yourself.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Mayo Clinic Pharmacy Residency Programs proslijedio/la je Tweet
Summer is just around the corner and so is the 2020
@MayoClinic Pharmacy Internship! Congratulations to the following students from pharmacy schools across the US who will join us for 10-weeks! (1/10)pic.twitter.com/KGG7HGNbeU
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Residents don't only learn new clinical knowledge each day - they also practice ongoing professional development. Today, PGY1 HSPA
@Dylan_Kosaski and his preceptor/RPD@scott_nei discussed the spacing effect as a technique to improve knowledge retention!#OTILTHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Mayo Clinic Pharmacy Residency Programs proslijedio/la je Tweet
Well-being Wednesday; A Residents Guide to Staying Organized. Perfect time of year to keep your drive, motivation, and organization into gear! We’ve made it half way, lets keep ourselves on track and continue to make progress everyday!
#wellbeingwednesday#twitterxpic.twitter.com/CEn3SHzEsw
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Here's another interview
#TipForRxStudents! Debra Droopad (PGY1 AZ) says "have open communication with preceptors as soon as you get an interview. Make sure to travel to the interview at least the night before in case you have car or flight issues! Good luck!"Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Mayo Clinic Pharmacy Residency Programs proslijedio/la je Tweet
So we know Vancomycin + PTZ
AKI
BUT is this duration dependent? What if we use it for <72h as empiric therapy?
PharmD team @MayoClinic shows short courses of PTZ/VAN were NOT associated with
AKI
= SHORT courses #shorterthebetter https://www.ncbi.nlm.nih.gov/pubmed/30165426/ …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In summary, TKI therapy has significantly
outcomes for patients with CML, and certain patients may continue to maintain response even with discontinuation of TKI therapy
Thank you @kutzke_jade! Join us again next week to learn the latest on EVALI from@HlavacekPharmD
pic.twitter.com/P4dUggT2rD
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For patients who discontinue TKI therapy, ongoing monitoring is key
pic.twitter.com/c0l8F87hiq
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Several studies have tested discontinuation of imatinib, dasatinib, and nilotimib. Treatment free response was observed in 33-61% of patients at varying lengths of follow up.pic.twitter.com/sXxQfBXSy4
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Most patients achieve a deep molecular response which is associated with a low risk of disease progression and high rate of long-term survival benefit. Could patients maintain response with decreased adverse drug events by discontinuing TKIs?pic.twitter.com/fHUNO8XLPA
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Asciminib is a TKI in the pipeline with a novel binding site that locks the BCR-ABL protein into an inactive confirmation. A recently published phase I study had promising results
pic.twitter.com/hOj1fdkpdu
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Response to the initial agent should be routinely assessed and adjusted according to detected BCR-ABL1.pic.twitter.com/uVaNyiqx2A
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Patients with intermediate- or high-risk score should be started on a 2nd generation TKI.pic.twitter.com/nazplv92v0
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The IRIS trial found significantly improved CML outcomes with imatinib, a 1st gen TKI; however, patients would continue to progress after 5-10 years, warranting the development of 2nd and 3rd gen agents.pic.twitter.com/fkW2skGRwG
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The chronic phase of CML is defined by < 15% blasts. Our goal is to maintain presenting patients within the chronic phase to prolong survival.

pic.twitter.com/D3VzKWodes
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In this week’s
#PGR,@kutzke_jade will discuss TKI therapy in CML. Stay tuned for live updates!pic.twitter.com/Fmb4bQzM1O
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don't miss "A Second and Third Look at TKI Management in CML" at Pharmacy Grand Rounds today at 11am, presented by
@kutzke_jade! The presentation is open to all and live streaming in the Mayo network.#TwitteRx#MedTwitterpic.twitter.com/5dqmtsg1xc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@kutzke_jade (PGY2 Oncology) will be presenting "A Second and Third Look at TKI Management in CML" at Pharmacy Grand Rounds tomorrow, 1/28, at 11am in Alfred Main 459. Be sure not to miss this one!#TwitteRx#MedTwitter@MayoHemeOncpic.twitter.com/2iSEYQH46Y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The importance of pharmacy presence in our pediatric ED was just reported in a new publication by former ED PGY2 Gabby Anderson and team members from
@MayoClinicEM! https://journals.lww.com/pec-online/Abstract/publishahead/Pediatric_Emergency_Department_Interventions_of.98005.aspx …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.